New Funding Models for Translational Medicine:
The Boston/Cambridge BioFinance Working Group

The MIT Laboratory for Financial Engineering hosted an invitation-only meeting at MIT on February 23, 2015 to explore new business models and financial vehicles for raising and deploying funds for early-stage biomedical research and drug development in a scalable and profitable manner. The meeting brought together a small group of stakeholders from financial institutions, institutional investors, foundations and endowments, and local-area academic medical centers and university research laboratories to engage in active dialogue regarding specific funding needs, potential business and legal structures for pooling intellectual property, and new sources of capital to fund such portfolios.